期刊文献+

接种DTaP-IPV/Hib五联疫苗后偶合横纹肌肉瘤死亡的1例流行病学分析

An Epidemiological Analysis of One Death Case of DTaP-IPV/Hib Vaccination Coupled with Rhabdomyosarcoma
下载PDF
导出
摘要 目的调查一起接种DTaP-IPV/Hib五联疫苗偶合反应。方法对武汉市某区报告的1例接种DTaPIPV/Hib五联疫苗偶合横纹肌肉瘤病例进行流行病学分析。结果病理诊断及免疫组化结果显示,患儿符合胚胎性横纹肌肉瘤的临床症状。疫苗合格有效,接种过程符合规范。结论该病例与接种DTaP-IPV/Hib五联疫苗无因果关联,属于偶合症。 Objective To investigate a case of DTaP-IPV/Hib vaccination coupling reaction.Methods An epidemiological analysis was carried out on a case of DTaP-IPV/Hib vaccination coupled with rhabdomyosarcoma reported in Wuhan.Results The pathological diagnosis and immunohistochemistry showed that the patient’s condition was consistent with the clinical symptoms of embryonal rhabdomyosarcoma.The vaccine was qualified and effective and vaccination met the specification.Conclusion There was no causal association between the case and the inoculation of DTaP-IPV/Hib vaccine,which was a coincident case.
作者 蔡黎 王胜龙 杨小兵 陈剑 赵德峰 童叶青 CAI Li;WANG Shenglong;TONG Yeqing(Wuhan Center for Disease Control and Prevention Wuhan,430015,China)
出处 《中国社会医学杂志》 2018年第6期641-642,共2页 Chinese Journal of Social Medicine
基金 湖北省创新技术专项项目(2017ADC061)
关键词 DTaP-IPV/Hib五联疫苗 胚胎性横纹肌肉瘤 偶合症 流行病学 DTaP-IPV/Hib Embryonal rhabdomyosarcoma Coincident case Epidemiology
  • 相关文献

参考文献1

二级参考文献6

  • 1Ii RC, Li FX, Li YP, et 01. Immunogenicity and Safety of a DTaP-IPV /I PRP-T Combined Vaccine (Pentaxim? ) at 2,3,4 months or 3,4,5 months versus separate vaccines (DTaP, PRP-T and IPV) in healthy Chinese infants[C]. 13th Asian Pacific Congress of Pe?diatrics, Shanghai: 2009, Ah. E2142.
  • 2Li RC, u FX, u YP, et 01. Antibody persistence at 18-20 months of age following primary vaccination of healthy infants with a Combined DTaP-IPV /I PRP-T Vaccine (Pentaxim? ) com?pared to separate vaccines (DTaP, PRP- T, and IPV) and im munogenicity and safety of booster vaccination in the Peoples' Republic of China[C]. 5th Asian Congress of Pediatric Infectious Diseases. Taipei: 2010.
  • 3Lagos R, Kotloff K, Hoffenhach A, et 01. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vac?cine containing diphtheria, tetanus, acellular pertussis, inacti?vated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants[I]. Pediatr Infect DisJ, 1998, 17 (4): 294-304.
  • 4Capeding MR,Cadorna-CarlosJ. Book-Montellano M, et 01. Im?munogenicity and safety of a DTaP-IPV /I PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial[J]. Bull World Health Organ, 2008,86(6): 443-451.
  • 5徐峰.无细胞百白破疫苗免疫接种安全性观察[J].浙江预防医学,2010,22(8):42-42. 被引量:4
  • 6吸附无细胞百白破、灭活脊髓灰质炎和b型流感嗜血杆菌(结合)联合疫苗(DTaP—IPV/Hib五联疫苗)应用技术指南[J].中华流行病学杂志,2011,32(3):311-315. 被引量:31

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部